Systemic aspergillosis caused by an aflatoxin-producing strain of Aspergillus flavus

References

• Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillus: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147–1201
   PubMedGoogle Scholar
• Denning DW. Therapeutic outcome in invasive aspergillus. Clin Infect Dis 1996; 23: 608–615
   PubMed Web of Science ®Google Scholar
• Obayashi, T, Yoshida, M, Mori, T, et al. Plasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17–20
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts. National Committee for Clinical Laboratory Standards, Villanova, PA 1992, Proposed standard M27-P
   Google Scholar
• Golas CL, Prober CG, MacLeod SM, Soldin SJ. Measurement of amphotericin B in serum or plasma by high-performance liquid chromatography. J Chromatogr 1983; 278: 387–395
   PubMed Web of Science ®Google Scholar
• Heykants, J, Van Peer, A, Van de Velde, V, et al. The clinical pharmacokinetics of itraconazole; an overview. Mycoses 1989; 32(Suppl. 1)67–87
   PubMedGoogle Scholar
• Davis ND, Diener UL, Eldridge DW. Production of aflatoxins B1 and G1 by Aspergillus flavus in a semisynthetic medium. Appl Microbiol 1966; 14: 378–380
   PubMedGoogle Scholar
• Gunasekaran M. Optimum culture conditions for aflatoxin B2 production by a human pathogenic strain of Aspergillus flavus. Mycologia 1981; 73: 697–704
   Google Scholar
• Schindler AF, Palmer JG, Eisenberg WV. Aflatoxin production by Aspergillus flavus as related to various temperatures. Appl Microbiol 1967; 15: 1006–1009
   PubMedGoogle Scholar
• Joffe AZ, Lisker N. Effects of light, temperature, and pH value on aflatoxin production in vitro. Appl Microbiol 1969; 18: 517–518
   PubMedGoogle Scholar
• Oyelami OA, Maxwell SM, Adelusola KA, Aladekoma TA, Oyelese AO. Aflatoxins in the autopsy brain tissue of children in Nigeria. Mycopathologia 1995; 132: 35–38
   Web of Science ®Google Scholar
• Shank RC, Bourgeois CH, Keschamras N, Chandavimol P. Aflatoxins in autopsy specimens from Thai children with an acute disease of unknown aetiology. Fd Cosmet Toxicol 1971; 9: 501–507
   PubMedGoogle Scholar
• Krishnamachari KAVR, Bhat RV, Nagarajan V, Tilak TBG. Hepatitis due to aflatoxicosis; an outbreak in western India. Lancet 1975; 1-2: 1061–1063
   Google Scholar
• Siraj, MY, Hayes, AW, Unger, PD, et al. Analysis of aflatoxin B1 in human tissues with high-pressure liquid chromatography. Toxicol Appl Pharmacol 1981; 58: 422–430
   PubMed Web of Science ®Google Scholar
• Kok WT. Derivatization reactions for the determination of aflatoxins by liquid chromatography with fluorescence detection. J Chromatogr B 1994; 659: 127–137
   PubMed Web of Science ®Google Scholar
• Polak A. Combination therapy with antifungal drugs. Mycoses 1988; 31: 45–53, (Suppl.)
   PubMedGoogle Scholar
• Scheven M, Schwegler F. Antagonistic interactions between azoles and amphotericin B with yeasts depend on azolelipophilia for special test conditions in vitro. Antimicrob Agents Chemother 1995; 39: 1779–1783
   PubMed Web of Science ®Google Scholar
• Pier AC. Mycotoxin and animal health. Adv Vet Sci Comp Med 1981; 25: 185–243
   PubMedGoogle Scholar
• Denning DW. Aflatoxin and human disease. Adv Drug React Ac Pois Rev 1987; 4: 175–209
   Google Scholar
• Takahashi T. Distribution and characteristics of aflatoxin-producing Aspergillus flavus in the soil in Kanagawa prefecture, central Japan. Mycopathologia 1993; 121: 169–173
   Google Scholar
• Pier AC, Belden EL, Ellis JA, Nelson EW, Maki LR. Effects of cyclopiazonic acid and aflatoxin singly and in combination on selected clinical, pathological and immunological responses of guinea pigs. Mycopathologia 1989; 105: 135–142
   PubMedGoogle Scholar
• Pier AC. Major biological consequences of alfatoxicosis in animal production. J Anim Sci 1992; 70: 3964–3967
   PubMed Web of Science ®Google Scholar
• Hall AJ, Wild CP. Aflatoxin biomarkers. Lancet 1992; 339: 1413–1414
   PubMedGoogle Scholar
• Hendrickse RG. Kwashiorkor: the hypothesis that incriminates aflatoxins. Paediatrics 1991; 88: 376–379
   PubMed Web of Science ®Google Scholar
• Ross, RK, Yuan, J-M, Yu, MC, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943–946
   PubMed Web of Science ®Google Scholar
• Autrup H, Seremet T, Wakhisi J, Wasunna A. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and heptatis B virus infection in areas with different liver cancer incidence in Kenya. Cancer Res 1987; 47: 3430–3433
   PubMed Web of Science ®Google Scholar
• Dugyala RR, Kim Y, Sharma RP. Effects of aflatoxin B1 and T-2 toxin on the granulocyte-macrophage progenitor cells in mouse bone marrow cultures. Immunopharmacology 1994; 27: 57–65
   PubMedGoogle Scholar
• Jakab GJ, Hmieleski RR, Zarba A, Hemenway DR, Groopman JD. Respiratory aflatoxicosis: suppression of pulmonary and systemic host defenses in rats and mice. Toxicol Appl Pharmacol 1994; 125: 198–205
   PubMed Web of Science ®Google Scholar
• Tang CM, Cohen J, Krausz T, Van Noorden S, Holden DW. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun 1993; 61: 1650–1656
   PubMed Web of Science ®Google Scholar